GMP: FDA´s Drug Safety Draft Guidance regarding REMS


On September 20, 2016, the Food and Drug Administration (FDA) published a draft guidance for industry on the "Application of Statutory Factors in Determining When a REMS Is Necessary" for comment. Comments and suggestions should be submitted within 60 days of publication in the Federal Register of the notice announcing the availability of the draft.